| GL806a |
Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| T175 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| T174a |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed
|
US Biomax
|
|
394.00 € |
|
Publication
|
| PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| T142a |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed
|
US Biomax
|
|
228.00 € |
|
Publication
|
| FMC405a |
Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed
|
US Biomax
|
|
487.00 € |
|
Publication
|
| FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed
|
US Biomax
|
|
162.00 € |
|
Publication
|
| OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| T385a |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| SO751 |
Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| FDA999a |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed
|
US Biomax
|
|
382.00 € |
|
Publication
|
| CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| FDA808a-1 |
Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed
|
US Biomax
|
|
228.00 € |
|
Publication
|
| T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| FMC407b |
Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| NHL802a |
Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax
|
|
487.00 € |
|
Publication
|
| LM482a |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed
|
US Biomax
|
|
320.00 € |
|
Publication
|
| T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| ME1004a |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed
|
US Biomax
|
|
210.00 € |
|
Publication
|
| ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| T141a |
Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| T176 |
Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| ME2082a |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed
|
US Biomax
|
|
429.00 € |
|
Publication
|
| BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| NHL401a |
Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| LY121a |
Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| FRA901a |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed
|
US Biomax
|
|
858.00 € |
|
Publication
|
| MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed
|
US Biomax
|
|
320.00 € |
|
Publication
|
| BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| TH802a |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| ST1004 |
Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| T203a |
Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed
|
US Biomax
|
|
210.00 € |
|
Publication
|
| T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| FMC409a |
Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax
|
|
210.00 € |
|
Publication
|
| T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| LM801a |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax
|
|
81.00 € |
|
Publication
|
| LY1001a |
Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| T034 |
Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| ST962 |
Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
228.00 € |
|
Publication
|
| SK245 |
Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| T343 |
Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| PRF281 |
Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed
|
US Biomax
|
|
742.35 € |
|
Publication
|
| LC488 |
Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| LV1502 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| LC1502 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| ES481 |
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed
|
US Biomax
|
|
210.00 € |
|
Publication
|
| LV2091 |
Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
429.00 € |
|
Publication
|
| FRA901a-2 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c
|
US Biomax
|
|
626.00 € |
|
Publication
|
| FDA902-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed
|
US Biomax
|
|
858.00 € |
|
Publication
|
| CO1502 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| FMC281 |
Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed
|
US Biomax
|
|
394.00 € |
|
Publication
|
| ST1503 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| RE1503 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| ON481 |
Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
162.00 € |
|
Publication
|
| MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
811.00 € |
|
Publication
|
| T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| FRA781-2 |
FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| FRA901a-1 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c
|
US Biomax
|
|
626.00 € |
|
Publication
|
| BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| MO541 |
Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
162.00 € |
|
Publication
|
| BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
228.00 € |
|
Publication
|
| T205 |
Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| UT961 |
Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
228.00 € |
|
Publication
|
| KD961 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax
|
|
296.00 € |
|
Publication
|
| GL803 |
Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases 80 cores, replacing BS17015
|
US Biomax
|
|
266.00 € |
|
Publication
|
| UT1501 |
Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| T214 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| T095 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| FRA781-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| T291a |
Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin
|
US Biomax
|
|
114.00 € |
|
Publication
|
| SF961 |
Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
228.00 € |
|
Publication
|
| T046 |
Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| LC961 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| CO1021 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
114.00 € |
|
Publication
|
| FBN401 |
Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
278.00 € |
|
Publication
|
| PR484 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
162.00 € |
|
Publication
|
| CO804a |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| FBN407a |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| CO488 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| PR956 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir
|
US Biomax
|
|
487.00 € |
|
Publication
|
| T144 |
Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| GL806 |
Brain glioblastoma and normal tissue array, 40 cases 80 cores, replacing GL805
|
US Biomax
|
|
266.00 € |
|
Publication
|
| OV961 |
Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
228.00 € |
|
Publication
|
| UT243 |
Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| T104 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| FRA901-2 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| T014 |
Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| CO962 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| CyFDA1 |
FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| RE1021 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
296.00 € |
|
Publication
|
| MBN481 |
Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| TH242 |
Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| T244 |
Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| T388 |
Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| KD1501 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| SK961 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| T125 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| GL805 |
Glioblastoma multiforme (GBM) tissue array, 40 cases 80 cores, replaced by GL806
|
US Biomax
|
|
266.00 € |
|
Publication
|
| LC817 |
Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| VLC12 |
Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| FRA901-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| CR1501 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
258.00 € |
|
Publication
|
| T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed
|
US Biomax
|
|
742.00 € |
|
Publication
|
| CR245 |
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
105.00 € |
|
Publication
|
| T024 |
Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
90.00 € |
|
Publication
|
| T174 |
Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171
|
US Biomax
|
|
88.00 € |
|
Publication
|
| FBN406a |
Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
394.00 € |
|
Publication
|
| CMA241a |
Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax
|
|
228.00 € |
|
Publication
|
| BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti-
|
US Biomax
|
|
296.00 € |
|
Publication
|
| FMO901-2 |
Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed
|
US Biomax
|
|
626.00 € |
|
Publication
|
| FFE302a |
Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
394.00 € |
|
Publication
|
| MO1601 |
Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011
|
US Biomax
|
|
278.00 € |
|
Publication
|
| BS17011 |
Brain glioblastoma tissue array, 21 cases 63 cores, replaced by GL811
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BS17018 |
Brain glioblastoma tissue array, 33 cases 63 cores, replaced by GL805
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax
|
|
185.00 € |
|
Publication
|
| PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed
|
US Biomax
|
|
487.00 € |
|
Publication
|
| GL2082 |
Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
|
US Biomax
|
|
296.00 € |
|
Publication
|
| GL208 |
Brain primary tumor high density (69 cases 208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue
|
US Biomax
|
|
456.00 € |
|
Publication
|
| GL811 |
Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011
|
US Biomax
|
|
266.00 € |
|
Publication
|
| CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax
|
|
429.00 € |
|
Publication
|
| MC542 |
Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541
|
US Biomax
|
|
160.00 € |
|
Publication
|
| BM483 |
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BS17016 |
Brain glioma tissue array, 33 cases 63 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| ST808 |
Stomach adenocarcinoma and normal tissue array, 80 cases 80 cores, replacing BS01032
|
US Biomax
|
|
231.00 € |
|
Publication
|
| T386 |
Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385
|
US Biomax
|
|
88.00 € |
|
Publication
|
| OS802 |
Osteosarcoma and chondrosarcoma tissue array, with stage, grade and TNM data, 80 cases 80 cores, replacing BC26111
|
US Biomax
|
|
266.00 € |
|
Publication
|
| LC10013 |
Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002
|
US Biomax
|
|
266.00 € |
|
Publication
|
| FMS151 |
Brains of multiple species frozen tissue array, 14 cases 15 cores
|
US Biomax
|
|
293.00 € |
|
Publication
|
| FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2
|
US Biomax
|
|
336.00 € |
|
Publication
|
| ES781 |
Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111
|
US Biomax
|
|
266.00 € |
|
Publication
|
| PR808 |
Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012
|
US Biomax
|
|
266.00 € |
|
Publication
|
| GL722 |
Brain glioma (astrocytoma) tissue array, 24 cases 72 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| LN802 |
Multiple organ lymph tissue array, 80 cases 80 cores, replacing LN801
|
US Biomax
|
|
231.00 € |
|
Publication
|
| GL804 |
Brain tumor and normal tissue array with grade and TNM data, 40 cases 80 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| MC631 |
Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014
|
US Biomax
|
|
160.00 € |
|
Publication
|
| ESC242 |
Esophagus cancer tissue array, 12 cases 24 cores; ihc H&E, IHC anti-Cytokeratin
|
US Biomax
|
|
205.00 € |
|
Publication
|
| LV805 |
Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001
|
US Biomax
|
|
231.00 € |
|
Publication
|
| NHL482 |
Lymphoma tissue array, 48 cases 48 cores, replacing NHL481
|
US Biomax
|
|
189.00 € |
|
Publication
|
| GL1921 |
Mid advanced stage brain tumor tissue array, including pathology grade, 96 cases 192 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a
|
US Biomax
|
|
456.00 € |
|
Publication
|
| CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002
|
US Biomax
|
|
321.00 € |
|
Publication
|
| GL808 |
Brain tumor tissue array, with matched adjacent normal tissue, 80 cases 80 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| MO17011 |
Mouse brain tissue array, 100 cases 100 cores, 50 male and 50 female
|
US Biomax
|
|
160.00 € |
|
Publication
|
| BC30013 |
Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax
|
|
160.00 € |
|
Publication
|
| T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BN129 |
Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116
|
US Biomax
|
|
160.00 € |
|
Publication
|
| CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241
|
US Biomax
|
|
189.00 € |
|
Publication
|
| NHL803 |
Lymphoma tissue array, 80 cases 80 cores, replacing LM802
|
US Biomax
|
|
266.00 € |
|
Publication
|
| GL241 |
Multiple brain cancer tissue array with self matching normal adjacent tissues, 10 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| CO724 |
Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031
|
US Biomax
|
|
278.00 € |
|
Publication
|
| FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995
|
US Biomax
|
|
314.00 € |
|
Publication
|
| PA802 |
Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BS17015 |
Brain glioma tissue array, 63 cases 63 cores, replaced by GL803
|
US Biomax
|
|
231.00 € |
|
Publication
|
| ST807 |
Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC19019 |
Prostate cancer and hyperplasia tissue array, 33 cases 63 cores, replacing BC19011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243
|
US Biomax
|
|
99.00 € |
|
Publication
|
| LC721 |
Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| FBN406 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404
|
US Biomax
|
|
167.00 € |
|
Publication
|
| BRN801 |
Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013
|
US Biomax
|
|
231.00 € |
|
Publication
|
| ME804 |
Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801
|
US Biomax
|
|
266.00 € |
|
Publication
|
| ST721 |
Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases 72 cores, replacing BC01011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012
|
US Biomax
|
|
231.00 € |
|
Publication
|
| GL721 |
Brain tumor and normal tissue array with TNM and grade info, 24 cases 72 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| CO806 |
Colon normal adjacent tissue array, replacing BN05012, 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BN00119 |
Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112
|
US Biomax
|
|
266.00 € |
|
Publication
|
| LV804 |
Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016
|
US Biomax
|
|
231.00 € |
|
Publication
|
| SK244 |
Age grouped female skin tissue array, 12 cases 24 cores, replacing SK243
|
US Biomax
|
|
99.00 € |
|
Publication
|
| LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001
|
US Biomax
|
|
231.00 € |
|
Publication
|
| TE242 |
Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241
|
US Biomax
|
|
88.00 € |
|
Publication
|
| FCO401a |
Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401
|
US Biomax
|
|
781.00 € |
|
Publication
|
| LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021
|
US Biomax
|
|
160.00 € |
|
Publication
|
| MCN602 |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601
|
US Biomax
|
|
231.00 € |
|
Publication
|
| GL1003 |
Brain tumor tissue array for antibody screening, 25 cases 100 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BL802 |
Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC17013 |
Brain astrocytoma and meningioma tissue array, 120 cases 120 cores
|
US Biomax
|
|
321.00 € |
|
Publication
|
| SO802 |
Malignant fibrohistiocytoma tissue array, 80 cases 80 cores; ihc CD68 confirmed
|
US Biomax
|
|
267.00 € |
|
Publication
|
| GL807 |
Brain glioma and normal tissue array, including pathology grade, 40 cases 80 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| MC801 |
Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade information
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax
|
|
429.00 € |
|
Publication
|
| LV809 |
Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BN126 |
Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115
|
US Biomax
|
|
266.00 € |
|
Publication
|
| PR803 |
Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases 80 cores, replacing PR801
|
US Biomax
|
|
231.00 € |
|
Publication
|
| CO723 |
Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05021
|
US Biomax
|
|
231.00 € |
|
Publication
|
| T173 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502
|
US Biomax
|
|
278.00 € |
|
Publication
|
| ES1202 |
Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201
|
US Biomax
|
|
278.00 € |
|
Publication
|
| T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085
|
US Biomax
|
|
88.00 € |
|
Publication
|
| FDA806 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax
|
|
380.00 € |
|
Publication
|
| PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015
|
US Biomax
|
|
231.00 € |
|
Publication
|
| ES722 |
Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023
|
US Biomax
|
|
231.00 € |
|
Publication
|
| GL482 |
Brain tumor tissue array, with normal tissue, 48 cases 48 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| FDA999 |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998
|
US Biomax
|
|
314.00 € |
|
Publication
|
| T392 |
Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BC21014 |
Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LC725 |
Normal lung tissue array, 24 cases 72 cores, replacing BN04011
|
US Biomax
|
|
278.00 € |
|
Publication
|
| BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861
|
US Biomax
|
|
266.00 € |
|
Publication
|
| GL1002 |
Brain tumor and normal tissue array, 50 cases 100 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| MC245 |
Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242
|
US Biomax
|
|
88.00 € |
|
Publication
|
| PA241b |
Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241
|
US Biomax
|
|
99.00 € |
|
Publication
|
| CR602 |
Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC17012 |
Medulloblastoma of brain tissue array, 100 cases 100 cores
|
US Biomax
|
|
277.00 € |
|
Publication
|
| CR803 |
Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases 80 cores, replacing BS10011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| FFE302 |
Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301
|
US Biomax
|
|
199.00 € |
|
Publication
|
| MO1002 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replacing MO32011
|
US Biomax
|
|
189.00 € |
|
Publication
|
| BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax
|
|
99.00 € |
|
Publication
|
| T195 |
Prostate adenocarcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, 2 serial sections, replacing T192
|
US Biomax
|
|
113.00 € |
|
Publication
|
| MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961
|
US Biomax
|
|
266.00 € |
|
Publication
|
| T084 |
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BO244 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243
|
US Biomax
|
|
100.00 € |
|
Publication
|
| GL2083 |
Brain tumor and normal tissue array with pathology grade, 208 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| MC483 |
Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data
|
US Biomax
|
|
160.00 € |
|
Publication
|
| CO722 |
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021
|
US Biomax
|
|
231.00 € |
|
Publication
|
| FDA901-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed
|
US Biomax
|
|
858.00 € |
|
Publication
|
| BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax
|
|
266.00 € |
|
Publication
|
| CNS801 |
Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores
|
US Biomax
|
|
314.00 € |
|
Publication
|
| BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| T172 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| T054 |
Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052
|
US Biomax
|
|
88.00 € |
|
Publication
|
| ME1004 |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003
|
US Biomax
|
|
314.00 € |
|
Publication
|
| LC808 |
Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC07015 |
Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| RE724 |
Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases 72 cores, replacing BS06041
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BR01015 |
Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011
|
US Biomax
|
|
278.00 € |
|
Publication
|
| GL481 |
Multiple brain cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores
|
US Biomax
|
|
160.00 € |
|
Publication
|
| MC5003 |
High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002
|
US Biomax
|
|
634.00 € |
|
Publication
|
| HER2 |
Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax
|
|
114.00 € |
|
Publication
|
| BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004
|
US Biomax
|
|
314.00 € |
|
Publication
|
| GL802 |
Glioblastoma (grade IV) tissue array, 40 cases 80 cores, replaced by GL805
|
US Biomax
|
|
231.00 € |
|
Publication
|
| MC616 |
High density lung, breast, brain and colon cancer array, with stage, grade and normal tissue array, 308 cases 616 cores
|
US Biomax
|
|
753.00 € |
|
Publication
|
| PA805 |
Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BS17017 |
Brain gliocytoma tissue array, 63 cases 63 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| RAT901 |
Rat multiple organs, normal tissue array, 22 cases 90 cores, replacing BR01013
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LC10012 |
Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006
|
US Biomax
|
|
266.00 € |
|
Publication
|
| LC724 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031
|
US Biomax
|
|
231.00 € |
|
Publication
|
| OS804 |
Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BN1002 |
Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961
|
US Biomax
|
|
266.00 € |
|
Publication
|
| LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014
|
US Biomax
|
|
231.00 € |
|
Publication
|
| OV20814 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084
|
US Biomax
|
|
558.00 € |
|
Publication
|
| BN501 |
Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013
|
US Biomax
|
|
160.00 € |
|
Publication
|
| GL1001 |
Multiple brain cancer and normal adjacent tissue array, 100 cases 100 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| MC244 |
Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2
|
US Biomax
|
|
277.00 € |
|
Publication
|
| ES8010 |
Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119
|
US Biomax
|
|
336.00 € |
|
Publication
|
| OV1005 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001
|
US Biomax
|
|
266.00 € |
|
Publication
|
| PR243 |
Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241
|
US Biomax
|
|
88.00 € |
|
Publication
|
| FDA800 |
Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2
|
US Biomax
|
|
266.00 € |
|
Publication
|
| PR8011 |
Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805
|
US Biomax
|
|
314.00 € |
|
Publication
|
| FDA901-1 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed
|
US Biomax
|
|
858.00 € |
|
Publication
|
| BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601
|
US Biomax
|
|
278.00 € |
|
Publication
|
| OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011
|
US Biomax
|
|
231.00 € |
|
Publication
|
| T171 |
Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases 24 cores, replaced by T174
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962
|
US Biomax
|
|
314.00 € |
|
Publication
|
| LC807 |
Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014
|
US Biomax
|
|
231.00 € |
|
Publication
|
| SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801
|
US Biomax
|
|
321.00 € |
|
Publication
|
| BN243 |
Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241
|
US Biomax
|
|
88.00 € |
|
Publication
|
| FDA805 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax
|
|
314.00 € |
|
Publication
|
| ME802 |
Malignant melanoma with normal skin tissue array, 40 cases 80 cores, replacing BS38011
|
US Biomax
|
|
266.00 € |
|
Publication
|
| RE723 |
Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases 72 cores, replacing BS06031
|
US Biomax
|
|
231.00 € |
|
Publication
|
| KD803 |
Normal kidney tissue array, replacing BN07012, 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| GL242 |
Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases 48 cores
|
US Biomax
|
|
189.00 € |
|
Publication
|
| MC5002 |
High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001
|
US Biomax
|
|
634.00 € |
|
Publication
|
| CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax
|
|
266.00 € |
|
Publication
|
| GL801 |
Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LC723 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071
|
US Biomax
|
|
231.00 € |
|
Publication
|
| OS803 |
Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011
|
US Biomax
|
|
266.00 € |
|
Publication
|
| FBN407 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404
|
US Biomax
|
|
281.00 € |
|
Publication
|
| ST723 |
Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042
|
US Biomax
|
|
231.00 € |
|
Publication
|
| PR809 |
Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases 80 cores, replacing BC19019
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001
|
US Biomax
|
|
456.00 € |
|
Publication
|
| PR955 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR954
|
US Biomax
|
|
558.00 € |
|
Publication
|
| MC641 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115
|
US Biomax
|
|
0.00 € |
|
Publication
|
| HN483 |
Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482
|
US Biomax
|
|
160.00 € |
|
Publication
|
| T045b |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045
|
US Biomax
|
|
99.00 € |
|
Publication
|
| BN01011b |
Normal stomach tissue array, 24 cases 72 cores, replacing BN01011
|
US Biomax
|
|
277.00 € |
|
Publication
|
| PR8010 |
Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax
|
|
189.00 € |
|
Publication
|
| LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212
|
US Biomax
|
|
266.00 € |
|
Publication
|
| MC802 |
Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information
|
US Biomax
|
|
266.00 € |
|
Publication
|
| HN811 |
Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BN05014 |
Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011
|
US Biomax
|
|
160.00 € |
|
Publication
|
| BR962 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013
|
US Biomax
|
|
231.00 € |
|
Publication
|
| FMC409 |
Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401
|
US Biomax
|
|
281.00 € |
|
Publication
|
| RE722 |
Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022
|
US Biomax
|
|
231.00 € |
|
Publication
|
| IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011
|
US Biomax
|
|
321.00 € |
|
Publication
|
| NHL803b |
Lymphoma tissue array, 80 cases 80 cores, replacing NHL803
|
US Biomax
|
|
321.00 € |
|
Publication
|
| CO725 |
Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05041
|
US Biomax
|
|
231.00 € |
|
Publication
|
| HN241 |
Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| CO803 |
Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| TMA2081 |
High density (156 cases 208 cores) tissue array of normal colon, prostate and breast tissue
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BC00014 |
Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631
|
US Biomax
|
|
160.00 € |
|
Publication
|
| FDA995 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997
|
US Biomax
|
|
278.00 € |
|
Publication
|
| MNO661 |
Normal organ tissue array of human, 66 cases 66 cores
|
US Biomax
|
|
189.00 € |
|
Publication
|
| PA803 |
Pancreatic duct adenocarcinoma and normal tissue array with TNM and grade info, 40 cases 80 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BR806 |
Breast hyperplasia tissue array, 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| RA161 |
Multiple organs normal tissue array of rat, 8 cases 16 cores
|
US Biomax
|
|
189.00 € |
|
Publication
|
| CO1921 |
High density colon cancer tissue array with normal tissues, 192 cases 192 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BC19021 |
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| OV805 |
Ovarian teratoma tissue array, 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LV8012 |
Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| SO809 |
Sarcoma tissue array of soft tissue (adipose, fibrous tissue, smooth muscles and striated muscles), 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LC722 |
Lung cancer and normal tissue array, with TNM and grade data, 24 cases 72 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC051111 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BR1504 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| LUC961 |
Lung cancer and normal tissue array, without overlapping with LUC962, 48 cases 96 cores
|
US Biomax
|
|
189.00 € |
|
Publication
|
| PR207b |
High density prostate cancer (1 4 grade) and normal prostate tissue array, 70 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| MC806 |
Gangliocytoma and paraganglioma tissue array, 40 cases 80 cores
|
US Biomax
|
|
278.00 € |
|
Publication
|
| COC1501 |
Colon cancer mid density tissue array, non overlapping with either COC1502 or COC1503, 75 cases 150 cores
|
US Biomax
|
|
0.00 € |
|
Publication
|
| SK2081 |
Skin disease spectrum (dermatic cancer progression) tissue array, 102 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| T063 |
Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| UR1001 |
Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases 100 cores
|
US Biomax
|
|
199.00 € |
|
Publication
|
| KD1002 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BC01001 |
Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BN08013 |
Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801
|
US Biomax
|
|
160.00 € |
|
Publication
|
| BRC1501 |
Breast cancer mid density tissue array, non overlapping with either BRC1502 or BRC1503, 75 cases 150 cores
|
US Biomax
|
|
225.00 € |
|
Publication
|
| CO2089 |
Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| ME207b |
High density (69 cases 207 cores), multiple primary melanoma, metastatic and normal skin tissue array block
|
US Biomax
|
|
40 981.00 € |
|
Publication
|
| BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BR485 |
Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax
|
|
397.00 € |
|
Publication
|
| LVC481 |
Liver cancer and normal tissue array, non overlapping with LVC482, 16 cases 48 cores
|
US Biomax
|
|
166.00 € |
|
Publication
|
| DGS2081 |
Digestive system tissue array, including TNM, stage and grade, 104 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| ST1921 |
Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| T212 |
Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| LC811 |
Lung cancer tissue array with normal tissues, 80 cases 80 cores
|
US Biomax
|
|
278.00 € |
|
Publication
|
| BC08013 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014
|
US Biomax
|
|
160.00 € |
|
Publication
|
| OV20812 |
Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BR2082 |
Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| LV20811 |
Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| CR2083 |
Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| RE2001 |
Rectum cancer high density (200 core) tissue array, 192 cases 208 cores
|
US Biomax
|
|
397.00 € |
|
Publication
|
| SK805 |
Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases 80 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| T091 |
Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| UV1001 |
Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases 100 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| KD242 |
Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| AG801 |
Adrenal tumor tissue array, 80 cases 80 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| LC20811 |
Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BC02111 |
Esophagus adenocarcinoma and normal tissue array, 23 cases 80 cores
|
US Biomax
|
|
189.00 € |
|
Publication
|
| NGL961 |
Nervous system glioma tissue array, 48 cases 96 cores
|
US Biomax
|
|
261.00 € |
|
Publication
|
| GIST801 |
Gastrointestinal stromal tumor (GIST) tissue array, 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| MC242 |
Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245
|
US Biomax
|
|
88.00 € |
|
Publication
|
| CO486 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax
|
|
397.00 € |
|
Publication
|
| T006 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| TH8010 |
Thyroid cancer and normal tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| PA2081 |
Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BR8010 |
Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LY2087 |
Lymphoma tumor survey tissue array (2 of 3), 208 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723
|
US Biomax
|
|
160.00 € |
|
Publication
|
| ST722 |
Stomach adenocarcinoma with self matched adjacent and normal tissue array, with stage and grade info, 24 cases 72 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| T271 |
Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BC11012 |
Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores
|
US Biomax
|
|
160.00 € |
|
Publication
|
| OV481 |
Ovarian cancer tissue array with unmatched normal adjacent tissues, 24 cases 48 cores, with stage and grade data
|
US Biomax
|
|
160.00 € |
|
Publication
|
| BR20834 |
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| LV245 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax
|
|
189.00 € |
|
Publication
|
| CR485 |
Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| RE803 |
Rectal cancer and normal tissue array, with TNM and grade info, 73 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| SO2084 |
Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BC04021 |
Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax
|
|
160.00 € |
|
Publication
|
| BR082 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores
|
US Biomax
|
|
112.00 € |
|
Publication
|
| PR954 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR955
|
US Biomax
|
|
456.00 € |
|
Publication
|
| CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| RE962 |
Rectum adenocarcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores
|
US Biomax
|
|
321.00 € |
|
Publication
|
| SO801 |
Soft tissue cancer tissue array, with matched or unmatched adjacent normal tissue, 78 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| LC483 |
Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores
|
US Biomax
|
|
160.00 € |
|
Publication
|
| BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| OR1001 |
Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| BR1003 |
Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data
|
US Biomax
|
|
266.00 € |
|
Publication
|
| LP801 |
Larynx and pharynx cancer tissue array, with matched adjacent normal tissue, 70 cases 80 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| HN482 |
Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483
|
US Biomax
|
|
160.00 € |
|
Publication
|
| CO807 |
Advanced colon cancer tissue array, with stage and grade info, 80 cases 80 cores
|
US Biomax
|
|
266.00 € |
|
Publication
|
| T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b
|
US Biomax
|
|
88.00 € |
|
Publication
|
| TP242 |
Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BC001113 |
Esophageal adenocarcinoma, cardia adenocarcinoma, normal esophageal and cardia tissue array, 50 cases 50 cores (previously cat ES501)
|
US Biomax
|
|
189.00 € |
|
Publication
|
| FDG281f |
Normal dog multiple organ frozen tissue array, 28 cases 28 cores
|
US Biomax
|
|
199.00 € |
|
Publication
|
| MO04011 |
Mouse lung tissue array, 100 cases 100 cores, 50 male and 50 female
|
US Biomax
|
|
160.00 € |
|
Publication
|
| BN01011 |
Normal stomach tissue (multi sites) array, 21 cases 63 cores, replaced by BN01011b
|
US Biomax
|
|
160.00 € |
|
Publication
|
| BR812 |
Breast cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, with TNM data
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BS26011 |
Osteosarcoma tissue array, 32 cases 63 cores, replaced by OS804
|
US Biomax
|
|
231.00 € |
|
Publication
|
| CO20810 |
Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| T421 |
Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BC23012 |
Testis tumor tissue array, 23 cases 63 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| OV811 |
Ovarian cancer tissue array with normal tissues from autopsy, 35 cases 80 cores, with stage and grade data
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BR244 |
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245
|
US Biomax
|
|
88.00 € |
|
Publication
|
| CXC1021 |
Cervix cancer tissue array, 102 cases 102 cores
|
US Biomax
|
|
225.00 € |
|
Publication
|
| SP482 |
Multiple spleen cancer tissue array with unmatched normal adjacent tissues, 28 cases 48 cores
|
US Biomax
|
|
160.00 € |
|
Publication
|
| T192 |
Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195
|
US Biomax
|
|
88.00 € |
|
Publication
|
| BC06011 |
Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores
|
US Biomax
|
|
160.00 € |
|
Publication
|
| OV1003 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|
| BR208 |
High density, multiple breast cancer (1 3 grade) and normal breast tissue array, 70 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| PR242 |
Multiple prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax
|
|
88.00 € |
|
Publication
|
| MC961 |
Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964
|
US Biomax
|
|
231.00 € |
|
Publication
|
| COC482 |
Colon cancer and normal tissue array, non overlapping with COC481 16 cases 48 cores
|
US Biomax
|
|
166.00 € |
|
Publication
|
| T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085
|
US Biomax
|
|
88.00 € |
|
Publication
|
| UT242 |
Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores
|
US Biomax
|
|
189.00 € |
|
Publication
|
| KD20811 |
Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax
|
|
456.00 € |
|
Publication
|
| LC1007 |
Lung tuberculosis tissue array with normal tissue, 48 cases 100 cores
|
US Biomax
|
|
231.00 € |
|
Publication
|